May 17, 2020

Are health wearables on the way out?

Health IT
Health Tracking
healthcare services
healthcare services
Catherine Sturman
3 min
There is an undercurrent of uncertainty surrounding the health wearables market. Since the technology hit the shelves back in the late 2000s, consumers...

There is an undercurrent of uncertainty surrounding the health wearables market. Since the technology hit the shelves back in the late 2000s, consumers have been heavily focused on tracking their activities through wearable devices – but could they soon be on the way out?

From a cost perspective, wearable devices have been implemented to enable healthcare costs to reduce, and give users greater flexibility and an increased awareness towards their health decisions. However, there has been a significant reduction in consumer demand, leading fitness wearable company Jawbone to close down and go into liquidation. Known as one of the pioneers of the health wearable market, the company was dogged by technical faults within its technologies, alongside inconsistent data tracking, leading to poor sales and product growth.

Without adding value for consumers, consumers have therefore abandoned the brand in their droves. Consequently, it has been reported that Jawbone have closed their wearable division and CEO Hosain Rahman is launching a new hardware and software service, Jawbone Health Hub, which will provide technologies that customers will not be able to without.

Additionally, technology giant Intel has also laid off up to 80% of its wearables business, and is placing an increased focus on augmented reality technologies, according to CNBC.

The winners in health wearables

Although Jawbone had consistently battled with rival wearable company Fitbit, who has also failed to reach its earnings estimates, the company remains afloat. With decreased revenue, it has been reported that the company is investing in its smartwatch technology, which can be utilised within the health domain, as well as wearable technology for those who suffer with sleep apnoea.

Amazon and Apple are also reportedly working on building valuable healthcare technologies, with Apple focusing on the management of diabetes (a huge market in the US), alongside providing daily tracking technology and increased engagement throughout. Amazon is also building a secret digital health team in order to further its business model, and is looking to sell pharmaceuticals through its online platform.

However, there are a number of smaller players who are building a number of consumables and wearables to support users manage ongoing conditions. Health start up AliveCor, for example, has collaborated with Apple in the development of its Apple Watch, according to Share Talk, and will support the detection of abnormal heart murmurs, which can lead to strokes.

There has also been an exponential boom in health apps, such as Belong, which supports the management for cancer patients. The app enables users to have a digital folder, where all paperwork is stored and records can be updated in partnership with a physician. It even enables users to partner with others going through a similar journey, providing increased patient engagement, and ensures patients do not feel alone throughout their recovery.

Increased opportunities?

With a number of products targeted at women (which have also been 20% higher in recent studies), the female health market is growing in prevalence within health wearables. For menstrual cramps, the development of the Livia device helps eradicate any uncomfortableness through the use of electrodes embedded into the mini device, which is secured onto the inside of a user’s trousers, providing a discreet, valuable piece of technology for the female market. Cyrcadia Health has also created a smart bra, with embedded sensors to support women keep an ongoing management of their breast health and will detect any early signs of ill health, such as cancer.



Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article